Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
19 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/19/2948861/0/en/ACELYRIN-INC-Announces-Positive-Results-from-Global-Phase-3-Clinical-Trial-of-Izokibep-in-Hidradenitis-Suppurativa-to-be-Highlighted-in-Late-Breaking-Oral-Presentation-at-EADV-2024.html
10 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/10/2943499/0/en/ACELYRIN-INC-Announces-Positive-Proof-of-Concept-Data-From-Phase-1-2-Clinical-Trial-of-Lonigutamab-as-a-Subcutaneous-Treatment-for-Thyroid-Eye-Disease-to-be-Presented-at-42nd-Annua.html
22 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/22/2934112/0/en/ACELYRIN-INC-to-Participate-in-Upcoming-Investor-Conferences.html
14 Aug 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/acelyrin-drops-two-izokibep-indications-and-slashes-staff-focus-looming-fight-amgen
13 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/13/2929600/0/en/ACELYRIN-INC-Announces-Positive-Phase-3-Data-for-Izokibep-in-Hidradenitis-Suppurativa-Focuses-Strategy-on-Lonigutamab-and-Reports-Second-Quarter-2024-Financial-Results.html
06 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/06/2925526/0/en/ACELYRIN-INC-to-Report-Second-Quarter-2024-Financial-Results-and-Corporate-Update-on-August-13-2024.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?